Tags

Type your tag names separated by a space and hit enter

Effects of human calcitonin on pain in the treatment of Tietze's syndrome.
Clin Ther 1985; 7(6):669-73CT

Abstract

Tietze's syndrome consists of pain, tenderness, and swelling of the costosternal or sternoclavicular joints. The etiology is unknown, although microtrauma or rare infections have been though to be responsible for the lesion. Conventional therapy consists of anti-inflammatory drugs, sometimes combined with chemotherapeutic agents and antibiotics. Surgery is usually deemed necessary for cases that do not respond to conventional therapy. Experience with the use of human calcitonin in five patients suffering from severe Tietze's syndrome who did not respond to conventional therapy is reported. Symptoms improved within seven days, and all symptoms and signs had disappeared after one month of treatment. The beneficial effects of calcitonin are believed to result from the hormone's well-known analgesic and immunomodulating effects.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

4075361

Citation

Ricevuti, G. "Effects of Human Calcitonin On Pain in the Treatment of Tietze's Syndrome." Clinical Therapeutics, vol. 7, no. 6, 1985, pp. 669-73.
Ricevuti G. Effects of human calcitonin on pain in the treatment of Tietze's syndrome. Clin Ther. 1985;7(6):669-73.
Ricevuti, G. (1985). Effects of human calcitonin on pain in the treatment of Tietze's syndrome. Clinical Therapeutics, 7(6), pp. 669-73.
Ricevuti G. Effects of Human Calcitonin On Pain in the Treatment of Tietze's Syndrome. Clin Ther. 1985;7(6):669-73. PubMed PMID: 4075361.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of human calcitonin on pain in the treatment of Tietze's syndrome. A1 - Ricevuti,G, PY - 1985/1/1/pubmed PY - 1985/1/1/medline PY - 1985/1/1/entrez SP - 669 EP - 73 JF - Clinical therapeutics JO - Clin Ther VL - 7 IS - 6 N2 - Tietze's syndrome consists of pain, tenderness, and swelling of the costosternal or sternoclavicular joints. The etiology is unknown, although microtrauma or rare infections have been though to be responsible for the lesion. Conventional therapy consists of anti-inflammatory drugs, sometimes combined with chemotherapeutic agents and antibiotics. Surgery is usually deemed necessary for cases that do not respond to conventional therapy. Experience with the use of human calcitonin in five patients suffering from severe Tietze's syndrome who did not respond to conventional therapy is reported. Symptoms improved within seven days, and all symptoms and signs had disappeared after one month of treatment. The beneficial effects of calcitonin are believed to result from the hormone's well-known analgesic and immunomodulating effects. SN - 0149-2918 UR - https://www.unboundmedicine.com/medline/citation/4075361/Effects_of_human_calcitonin_on_pain_in_the_treatment_of_Tietze's_syndrome_ DB - PRIME DP - Unbound Medicine ER -